The First Editorial Board Meeting of Journal of Cancer Metastasis and Treatment in 2021 was Successfully Held

Published on: 1 Jul 2021 Viewed: 2060

The First Editorial Board Meeting of Journal of Cancer Metastasis and Treatment (JCMT) in 2021 was successfully held on June 21, 2021. 47 Editorial Board members from 12 countries participated in the meeting. They come from the United States, France, China, Japan, Italy, Germany, etc.

The Editor-in-Chief, Professor Lucio Miele, presided over this meeting. He organized the agenda of this important meeting with the topic, Objective: Impact Factor 5.

Firstly, he presented the annual report of 2020 to the participants, including the submissions and publications, special issues, readership, citations, and new Editorial Board members. All of these contents were showed with specific data, figures, and tables. It was clearly displayed the development and progress of JCMT in 2020, which are completely based on the support of the Editorial Board members.

Secondly, Professor Lucio Miele raised some questions around the topic of this meeting for participants to discuss. When talked about the promotion of JCMT, Professor Jan Vermorken expressed his views and emphasized the importance of mainstream social media, such as Twitter. Meanwhile, he also commented on the significance of the Chinese periodical market and appealed to more Chinese experts to join us for the better development of JCMT. In addition, Professor Gopal Kundu, Professor Ava Kwong, and Professor Tingchang Chang, and other attendees also gave their suggestions to the advances of JCMT.

Finally, after a heated discussion, Professor Lucio Miele made a short conclusion about this meeting and expressed his gratitude to all of the participants. This is the first Editorial Board meeting in 2021 and the most momentous meeting to JCMT. We believe that JCMT will indeed develop even better in the future with the guidance and support of the Editorial Board members.

Thanks for the support of the following Editorial Board members to this meeting (listed in no particular order):

1.Lucio Miele, the Director for Inter-Institutional Programs, LSU Health Sciences Center - New Orleans, United States.
2.Israël Vlodavsky, The Ruth and Bruce Rappaport Faculty of Medicine, Israel.
3.Jan Baptist Vermorken, the founding chair of the Gynecologic Cancer InterGroup, Universiteit Antwerpen, Belgium.
4.Heiko Hermeking, German Cancer Research Center, Germany.
5.William P. Schiemann, Co-Director of the Case Comprehensive Cancer Center, Case Western Reserve University, United States.
6.Masayuki Watanabe, Cancer Institute Hospital of Japan Foundation for Cancer Research, Japan.
7.Tingchang Chang, Professor and Co-Chairman at Chang-Gung University, Chang Gung Memorial Hospital, Taiwan.
8.Ava Kwong, Chief of Breast Surgery Division, Director of the Hong Kong Hereditary Breast Cancer Family Registry, the University of Hong Kong, Hong Kong (China).
9.Gopal Kundu, Director R&D at KIIT Deemed to be University, Institute of Eminence, India.
10.Judy Crabtree, Scientific and Education Director, Precision Medicine Program Director, LSUHSC School of Medicine, United States.
11.Yaguang Xi, Professor and Vice Chair for Research of the Department of Genetics, LSUHSC School of Medicine, United States.
12.Guofeng Xie, University of Maryland School of Medicine, United States.
13.Rafat A. Siddiqui, Director of the Nutrition and Food Science Laboratory, Virginia State University, United States.
14.Pravin Potdar, Jaslok Hospital & Research Centre, India.
15.Thomas Liehr, Institute of Human Genetics, Germany.
16.Ira-Ida Skvortsova, Tyrolean Cancer Research Institute, Austria.
17.Reinhold Munker, University of Kentucky HealthCare, United States.
18.Alessio Metere, Università degli Studi di Roma La Sapienza, Italy.
19.Paula A. Videira, CDG & Allies - Professionals and Patient Associations International Network (CDG & Allies - PPAIN), Portugal.
20.Boris Reva, Icahn School of Medicine at Mount Sinai, United States.
21.William L. Blalock, IRCCS Rizzoli Orthopaedic Institute, Bologna, Italy.
22.Barbara Azzimonti, University of Piemonte Orientale, Italy.
23.Xuefen Le Bourhis, University of Lille, France.
24.Arpan De, University of Texas MD Anderson Cancer Center, United States.
25.Dario De Biase, Alma Mater Studiorum Università di Bologna, Italy.
26.Simon K. Cheng, Vagelos College of Physicians and Surgeons, United States.
27.Alan Wang, University of Texas MD Anderson Cancer Center, United States.
28.Hindie Elif, Centre Hospitalier Universitaire de Bordeaux, France.
29.Minoru Fukuda, Nagasaki University Clinical Oncology Center, Japan.
30.Heike Allgayer, Ruprecht Karls University Heidelberg, Germany.
31.Andrea Nicolini, University of Pisa, Italy.
32.Awada Ahmad, Institut Jules Bordet, Belgium.
33.Ribatti Domenico, Università degli Studi di Bari, Italy.
34.Alfio Ferlito, Director of the Department of Surgical Sciences, Coordinator of the International Head and Neck Scientific Group, Italy.
35.Yangchao Chen, Chinese University of Hong Kong, Hong Kong (China).
36.Francesca Demichelis, University of Trento, Italy.
37.Curigliano Giuseppe, Director of New Drugs and Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Italy.
38.Gariboldi Marzia Bruna, University of Insubria, Italy.
39.Piyush Kumar Gupta, Sharda University, India.
40.Lisa Lee-Jones, Manchester Metropolitan University, United Kingdom.
41.Laurence Baker, University of Michigan Medical School, United States.
42.Gary Li, Oncology Ignyta, Inc, United States.
43.Surya K. Tripathi, Department of Life Science, India.
44.Ahmad R. Safa, Indiana University School of Medicine, United States.
45.Ren Xu, University of Kentucky, United States.
46.Ravi Sahu, Wright State University, United States.
47.Marco Fioramonti, Université Libre de Bruxelles, Belgium.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: